The hype surrounding hydroxychloroquine (HCQ) as a potential treatment for COVID-19 has led to problems for patients who use the drug to treat conditions like lupus, leading to shortages in pharmacies and worries about potentially dangerous side-effects, according to rheumatologists. Read more in The Lancet Rheumatology.
rheumatology
Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology
Excitement about a potential new treatment for the coronavirus disease 2019 (COVID-19) pandemic currently engulfing the world is causing problems for patients with arthritis and systemic lupus erythematosus (SLE), who routinely use the drug to control their symptoms. Read more in The Lancet Rheumatology.